文献速递垂体与肾上腺疾病性腺与生殖内分泌

457例21-羟化酶缺乏症基因型谱的临床与生化表型

Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该回顾性研究纳入美国NIH临床中心自然史研究的457例21-羟化酶缺乏症患者,采用更新遗传学方法分析基因型与临床生化表型的关系。研究发现多数为复合杂合,46%携带嵌合等位基因/30-kb缺失,10.1%为CAH-X,3.7%基因型-表型不一致;诊断时17OHP水平随基因型组不同,但临床诊疗中最大值在经典和非经典组内相似。结论认为疾病表型呈连续谱,生化重叠随年龄增加,建议嵌合亚型分型和将P30L视为独立组以指导遗传咨询和管理。

要点

  • 多数21OHD为复合杂合,46%携带嵌合等位基因/30-kb缺失,10.1%为CAH-X。
  • 诊断时17OHP因基因型组而异,但诊疗中最大值在经典或非经典组内相似。
  • P30L组诊断时17OHP更高、皮质醇更低,更易出现基础17OHP>1000 ng/dL。

核心结论

  • 21OHD疾病表型呈连续谱,生化重叠随年龄增加。
  • 提高基因型准确性(包括嵌合亚型分型以识别衰减嵌合体和CAH-X)并将P30L视为独立组,对遗传咨询和疾病管理有指导意义。

研究设计与样本

  • 回顾性研究,纳入美国国立卫生研究院临床中心自然史研究的457例21OHD个体。
  • 采用更新遗传学方法分析基因型谱与临床生化表型。

主要发现

  • 79%为复合杂合,46%携带嵌合等位基因/30-kb缺失(其中2.6%为衰减嵌合体),10.1%为CAH-X(33%伴心脏缺陷),3.7%存在基因型-表型不一致。
  • 失盐型、单纯男性化型和非经典型中最常见突变分别为In2G、I172N和V281L。
  • 罕见或新发突变占4.3%等位基因,0.33%为新发。
  • 诊断时17OHP水平按基因型组不同:Null > In2G > 单纯男性化型基因型 > P30L > 其他非经典型(P < .001);但临床诊疗中随时间获得的最大值在所有经典型之间及所有非经典型之间相似。
  • P30L个体诊断时17OHP更高、皮质醇更低(P < .001),更易出现基础17OHP >1000 ng/dL(P < .001);隐性非经典型CAH个体cosyntropin刺激后17OHP低于症状性非经典型CAH(P = .02)。

临床怎么用

  • 当激素检测结果不明确时,基因检测有助于分子确诊和遗传咨询。
  • 基因分型应包含嵌合亚型以识别衰减嵌合体和CAH-X,并将P30L作为独立组考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Genetic testing for 21-hydroxylase deficiency (21OHD) is advantageous when hormonal testing is equivocal, to molecularly confirm diagnosis, and for genetic counseling. OBJECTIVE: To characterize the clinical and biochemical phenotype across the genotypic spectrum of 21OHD in a large cohort using updated genetic methodology. DESIGN: Retrospective study of 457 individuals with 21OHD enrolled in a Natural History Study at the National Institutes of Health Clinical Center. RESULTS: The majority (79%) were compound heterozygous, 46% with chimeric alleles/30-kb deletions including 2.6% with attenuated chimeras, 10.1% with CAH-X (33% with cardiac defects), and 3.7% with genotype-phenotype discordance. The most common mutations among individuals with salt-wasting, simple-virilizing, and nonclassic (NC) phenotypes were In2G, I172N, and V281L, respectively. Rare or novel mutations accounted for 4.3% alleles, 0.33% arose de novo. 17OHP levels at diagnosis varied by genotype group (Null > In2G > simple-virilizing genotypes > P30L > Other NC; P < .001); but maximum values obtained during clinical care over time were similar among all classic and among all NC genotypes. Individuals with P30L had higher 17OHP and lower cortisol at diagnosis compared to other NC genotypes (P < .001) and were more likely to have basal 17OHP >1000 ng/dL (P < .001). Individuals with cryptic NC CAH had lower 17OHP after cosyntropin stimulation compared to those with symptomatic NC CAH (P = .02). CONCLUSION: A continuum of disease phenotypes exists with biochemical overlap that increases with age. Improving genotype accuracy to include chimera subtyping to identify attenuated chimeras and CAH-X and consideration of P30L as a unique group are important to guide genetic counseling and provide anticipatory guidance in disease management.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lao Q, Schulman A, Kulkarni S, et al. Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals. J Clin Endocrinol Metab. 2026. PMID: 41051294. doi:10.1210/clinem/dgaf546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。